Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients.
Laskari K, Tektonidou MG, Katsiari C, Athanassiou P, Dimopoulou D, Gerodimos C, Salamaliki C, Papagoras C, Settas L, Vassilopoulos D, Voulgari PV, Zakalka M, Georgiadis A, Gkoni G, Daoussis D, Dimitroulas T, Iliou C, Kallitsakis I, Grika EP, Mavragani C, Pikazis D, Raftakis J, Sarikoudis T, Kougkas N, Soukera D, Theodorou E, Tsatsani P, Tsiakou E, Vlachoyiannopoulos P, Vosvotekas G, Sfikakis PP.
Laskari K, et al. Among authors: salamaliki c.
Semin Arthritis Rheum. 2021 Feb;51(1):137-143. doi: 10.1016/j.semarthrit.2020.10.011. Epub 2020 Dec 19.
Semin Arthritis Rheum. 2021.
PMID: 33383289